Search

Additional file 1: Supplemental Figure 1. Number of organizations and facilities where SCC has been implemented in the past and current use. Supplemental Table 1. Adaptations to SCC Content and Structure from Interviews. Supplemental Table 2. SCC Implementation Approaches from Interviews.

Additional file 1. Health centers selected for Phase 1&2 studies (pre- and post-QI).

Additional file 2: Supplemental Table 1. Most Commonly Expressed Themes in Responses to Open-ended Questions. Table summarizing the results of the qualitative coding of open-ended responses using the consolidated criteria for reporting qualitative research. The most commonly expressed themes in responses to open-ended questions are presented.

Additional file 1. Survey.pdf: A pdf copy of the survey that was sent to eligible alumni.

Mycoplasma genitalium is a facultative anaerobic organism and a recognized cause of nongonococcal urethritis in men. In women, M. genitalium has been associated with cervicitis, endometritis, pelvic inflammatory disease (PID), infertility, susceptibility to human immunodeficiency virus (HIV), and adverse birth outcomes, indicating a consistent relationship with female genital tract pathology. The global prevalence of M. genitalium among symptomatic and asymptomatic sexually active women ranges between 1 and 6.4%. M. genitalium may play a role in pathogenesis as an independent sexually transmitted pathogen or by facilitating coinfection with another pathogen. The long-term reproductive consequences of M. genitalium infection in asymptomatic individuals need to be investigated further. Though screening for this pathogen is not currently recommended, it should be considered in high-risk populations. Recent guidelines from the Centers for Disease Control regarding first-line treatment for PID do not cover M. genitalium but recommend considering treatment in patients without improvement on standard PID regimens. Prospective studies on the prevalence, pathophysiology, and long-term reproductive consequences of M. genitalium infection in the general population are needed to determine if screening protocols are necessary. New treatment regimens need to be investigated due to increasing drug resistance.

Tuberculosis (TB) infection poses substantial challenges for obstetricians and gynecologists globally, as gynecologic involvement may cause infertility, irregular bleeding, and pelvic pain. If TB-infected women are able to conceive, obstetric complications include intrauterine growth restriction and, more rarely, congenital transmission. Appropriate screening for high-risk populations is crucial for diagnosis and treatment of latent and active TB infection, which may prevent reproductive sequelae for individual patients and, eventually, contribute to complete eradication of the disease.